CoChat

The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial

The DOI matches its Crossref record; 30 of the 34 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Sleep disorders affect many patients with chronic pain conditions. Cannabis has been reported by several patient populations to help sleep. We evaluated the safety and efficacy of nabilone, a synthetic cannabinoid, on sleep disturbance in fibromyalgia (FM), a disease characterized by widespread chronic pain and insomnia. METHODS: We conducted a randomized, double-blind, active-control, equivalency crossover trial to compare nabilone (0.5-1.0 mg before bedtime) to amitriptyline (10-20 mg before bedtime) in patients with FM with chronic insomnia. Subjects received each drug for 2 wk with a 2-wk washout period. The primary outcome was sleep quality, measured by the Insomnia Severity Index and the Leeds Sleep Evaluation Questionnaire. Secondary outcomes included pain, mood, quality of life, and adverse events (AEs). RESULTS: Thirty-one subjects were enrolled and 29 completed the trial (26 women, mean age 49.5 yr). Although sleep was improved by both amitriptyline and nabilone, nabilone was superior to amitriptyline (Insomnia Severity Index difference = 3.2; 95% confidence interval = 1.2-5.3). Nabilone was marginally better on the restfulness (Leeds Sleep Evaluation Questionnaire difference = 0.5 [0.0-1.0]) but not on wakefulness (difference = 0.3 [-0.2 to 0.8]). No effects on pain, mood, or quality of life were observed. AEs were mostly mild to moderate and were more frequent with nabilone. The most common AEs for nabilone were dizziness, nausea, and dry mouth. CONCLUSIONS: Nabilone is effective in improving sleep in patients with FM and is well tolerated. Low-dose nabilone given once daily at bedtime may be considered as an alternative to amitriptyline. Longer trials are needed to determine the duration of effect and to characterize long-term safety.

Overview

Integrity signals

Registry

Crossref · 10.1213/ane.0b013e3181c76f70

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 30 references

Cited by

See all 324

Metadata

Authors
Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y.
Affiliations
  • McGill University Health Centre (CA)
  • McGill University (CA)
Corresponding author
  • Ware, Mark A.
  • Shir, Yoram
Venue
Anesthesia & Analgesia
Published
2010-02
Volume
110
Issue
2
Pages
604-610
ISSN
0003-2999 (ISSN-L)
OpenAlex
W1998257682
Cited by
324
References
34
Citations by year
2026: 12 · 2025: 36 · 2024: 22 · 2023: 15 · 2022: 34 · 2021: 31 · 2020: 29 · 2019: 13 · 2018: 17 · 2017: 21 · 2016: 21 · 2015: 13 · 2014: 21 · 2013: 11 · 2012: 14
FWCI
9.98
Type
journal article
Language
en
Open access
closed
Locations
  • Anesthesia & Analgesia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Keywords
nabilone, fibromyalgia, insomnia, sleep quality, cannabis, synthetic cannabinoids, amitriptyline, chronic pain, adverse events, drug safety and efficacy
MeSH terms
Adult, Aged, Amitriptyline, Antidepressive Agents, Double-Blind Method, Female, Fibromyalgia, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Pain Measurement, Sleep, Dronabinol, Anti-Anxiety Agents, Patient Satisfaction, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial. https://app.cochat.ai/papers/10.1213/ane.0b013e3181c76f70
The paper
Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y. (2010). The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0b013e3181c76f70

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.